2021
European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer
VAN KALSBEEK, R. J ., H. J. H. VAN DER PAL, L. C. M. KREMER, E. BARDI, M. C. BROWN et. al.Základní údaje
Originální název
European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer
Autoři
VAN KALSBEEK, R. J . (garant), H. J. H. VAN DER PAL, L. C. M. KREMER, E. BARDI, M. C. BROWN, R. EFFENEY, J. F. WINTHER, C. FOLLIN, J. DEN HARTOGH, R. HAUPT, L. HJORTH, Tomáš KEPÁK (203 Česká republika, domácí), Kateřina KEPÁKOVÁ (203 Česká republika, domácí), G. LEVITT, J. J. LOONEN, M. MANGELSCHOTS, M. MURACA, M. RENARD, H. SABIC, C. U. SCHNEIDER, A. UYTTEBROECK, R. SKINNER a R. L. MULDER
Vydání
European Journal of Cancer, Oxford, Elsevier Science Inc. 2021, 0959-8049
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 10.002
Kód RIV
RIV/00216224:14110/21:00124150
Organizační jednotka
Lékařská fakulta
UT WoS
000686049700036
Klíčová slova anglicky
Neoplasms; Cancer survivors; Survivorship; Aftercare; Practice guideline; Patient participation; Quality of life
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 15. 2. 2022 08:31, Mgr. Tereza Miškechová
Anotace
V originále
Background: Long-term follow-up (LTFU) care for childhood, adolescent, and young adult (CAYA) cancer survivors is essential to preserve health and quality of life (QoL). Evidence-based guidelines are needed to inform optimal surveillance strategies, but many topics are yet to be addressed by the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG). Therefore, the PanCareFollowUp Recommendations Working Group collaborated with stakeholders to develop European harmonised recommendations in anticipation of evidence-based IGHG guidelines. Methods: The PanCareFollowUp Recommendations Working Group, consisting of 23 late effects specialists, researchers, and survivor representatives from nine countries, collaborated in the first Europe-wide effort to provide unified recommendations in anticipation of evidence based guidelines. A pragmatic methodology was used to define recommendations for topics where no evidence-based IGHG recommendations exist. The objective was to describe the surveillance requirements for high-quality care while balancing the different infrastructures and resources across European health care systems. The process included two face-to-face meetings and an external consultation round involving 18 experts from 14 countries. Results: Twenty-five harmonised recommendations for LTFU care were developed collaboratively and address topics requiring awareness only (n = 6), awareness, history and/or physical examination (n = 9), or additional surveillance tests (n = 10). Conclusions: The PanCareFollowUp Recommendations, representing a unique agreement across European stakeholders, emphasise awareness among survivors and health care providers in addition to tailored clinical evaluation and/or surveillance tests. They include existing IGHG guidelines and additional recommendations developed by a pragmatic methodology and will be used in the Horizon 2020-funded PanCareFollowUp project to improve health and QoL of CAYA cancer survivors. (C) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).